ArticlebioRxiv : the preprint server for biology2023
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML.
James M Kelvin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.